Cointime

Serenus Biotherapeutics

company

About

Serenus Biotherapeutics is a privately held specialty biopharmaceutical company

  • 11 - 50

Highlights

Total Funding Amount
$43M
Funding Rounds
1
Investors
1
Investments
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$43M
Industries
Biotechnology,Health Care,Natural Resources
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

Serenus Biotherapeutics is a privately held specialty biopharmaceutical company that specializes in late-stage drug development, in-licensing, registering, and commercializing therapies approved in the United States, Europe, and Japan to address unmet medical needs with high regional prevalence in the African market.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$43M
Serenus Biotherapeutics has raised a total of $43M in funding over 2 rounds. Their latest funding was raised on Mar 3, 2015 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 3, 2015 Series Unknown $43M 1 Malin Corporation — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Serenus Biotherapeutics has made 1 investments. Their most recent investment was on Jul 12, 2022, when Morpho Labs raised $18M.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 12, 2022 Morpho Labs
Seed $18M Blockchain —

Investors

Number of Lead Investors
Number of Investors
1
1
Serenus Biotherapeutics is funded by 1 investors. Malin Corporation are the most recent investors.
Investor Name Lead Investor Funding Round
Malin Corporation Yes Series Unknown
Cointime
Content
Company